⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | ICICI Prudential Nifty Pharma Index Fund - IDCW Payout - Direct Plan | Tata Silver Exchange Traded Fund |
|---|---|---|
| Snapshot | ||
| AMC | — | Tata MF |
| Category | Index Funds - Other | ETFs - Silver |
| NAV | ₹20.28 (15 Sep 2026) | ₹21.88 (15 Sep 2026) |
| Rating | ★★★★★ | ★★★ |
| Benchmark | NIFTY PHARMA - TRI | Silver |
| Fund Manager | Nishit Patel | Tapan Patel |
| Inception | 14 Dec 2022 | 12 Jan 2024 |
| Returns | ||
| 1Y | 18.11% | 76.78% |
| 3Y | 18.92% | — |
| 5Y | — | — |
| Since Inception | 20.72% | 52.09% |
| Risk | ||
| 14.58 | 42.35 | |
| 0.99 | -3.82 | |
| 1.05 | 1.40 | |
| -0.79 | 60.08 | |
| 2.40 | 3.69 | |
| -9.64% | -25.78% | |
| Costs | ||
| Expense Ratio | 0.52% | 0.39% |
| Exit Load | Nil | — |
| Min SIP | ₹1,000 | — |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
Portfolio holdings aren't disclosed for one or both funds, so overlap can't be computed.
Category context: Index / ETF vs Index / ETF. Open the full Screener →